Filing Details
- Accession Number:
- 0001209191-11-059499
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-12-05 16:37:13
- Reporting Period:
- 2011-12-01
- Filing Date:
- 2011-12-05
- Accepted Time:
- 2011-12-05 16:37:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1301081 | Pharmasset Inc | VRUS | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1397329 | Michelle M Berrey | 303A College Road East Princeton NJ 08540 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-12-01 | 3,126 | $6.84 | 3,126 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-12-01 | 3,126 | $130.33 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-12-01 | 3,126 | $10.83 | 3,126 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-12-01 | 3,126 | $130.33 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-12-01 | 3,126 | $0.00 | 3,126 | $6.84 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-12-01 | 3,126 | $0.00 | 3,126 | $10.83 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-10-10 | No | 4 | M | Direct | |
| 25,000 | 2019-10-14 | No | 4 | M | Direct |
Footnotes
- This transaction is the result of standing instructions set forth in a Rule 10b5-1 plan previously established by filer.
- The number of shares beneficially owned reflected in Items 5 and 9 of this Form 4 represent a two-for-one stock split (the "Split") of the Issuer's common stock which is structured in the form of a dividend payable on August 31, 2011 to the stockholders of record at the close of business August 22, 2011.
- A total of 25,000 pre-Split (50,000 post-Split) options were granted on 10/10/2007. Shares vest on the following schedule: 25% on the first anniversary of the grant, and 6.25% quarterly thereafter.
- A total of 25,000 pre-Split (50,000 post-Split) options were granted on 10/14/2009. Shares vest on the following schedule: 25% on the first anniversary of the grant, and 6.25% quarterly thereafter.
Billionaire Hedge Funds
